These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 8677994

  • 1. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 3. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
    Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG.
    Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340
    [Abstract] [Full Text] [Related]

  • 4. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.
    Colonna T, Korelitz BI.
    Am J Gastroenterol; 1994 Mar; 89(3):362-6. PubMed ID: 8122645
    [Abstract] [Full Text] [Related]

  • 5. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 6. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [Abstract] [Full Text] [Related]

  • 7. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.
    Levine DS, Fischer SH, Christie DL, Haggitt RC, Ochs HD.
    Am J Gastroenterol; 1992 Jan; 87(1):91-100. PubMed ID: 1728132
    [Abstract] [Full Text] [Related]

  • 8. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 9. Intravenous cyclosporin in ulcerative colitis: a five-year experience.
    Cohen RD, Stein R, Hanauer SB.
    Am J Gastroenterol; 1999 Jun; 94(6):1587-92. PubMed ID: 10364029
    [Abstract] [Full Text] [Related]

  • 10. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM.
    J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 12. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
    George J, Present DH, Pou R, Bodian C, Rubin PH.
    Am J Gastroenterol; 1996 Sep; 91(9):1711-4. PubMed ID: 8792685
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS, Sorof JM, Brewer ED, Kale AS.
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [Abstract] [Full Text] [Related]

  • 14. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R, REACH Study Group.
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 16. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.
    Adler DJ, Korelitz BI.
    Am J Gastroenterol; 1990 Jun; 85(6):717-22. PubMed ID: 1972315
    [Abstract] [Full Text] [Related]

  • 17. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
    Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
    [Abstract] [Full Text] [Related]

  • 18. High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease.
    Hermida-Rodriguez C, Cantero Perona J, Garcia-Valriberas R, Pajares Garcia JM, Mate-Jimenez J.
    Hepatogastroenterology; 1999 Oct; 46(28):2265-8. PubMed ID: 10521978
    [Abstract] [Full Text] [Related]

  • 19. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 20. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.